Lemonade Inc. is expected to print $1.29 of loss per share in the fiscal second quarter
A recap of lemonade's performance since its initial public offering in July.
avatar
Khan is a professional trader and business writer with over 7 years of experience in several financial markets. Khan takes pride in sharing insightful articles with his readers that help them improve their investment portfolios.
2020-08-11 09:00

Lemonade Inc. (NYSE: LMND) is scheduled to publish its financial results for the fiscal second quarter that concluded in June on Wednesday before the market open. The earnings report is expected to be the major market mover for the company on August 12th. Lemonade had its Initial Public Offering (IPO) in July and kicked off with a surprising bang. Many investors believe that the company will be the Amazon of Insurance. After debuting in the stock market, Lemonade only took two weeks to surge a massive 139% and more than doubled its share price.

Lemonade priced its shares at $29 in its IPO. The insurance company had originally estimated the range of $23 to $26 for its IPO and had later raised it to $28. The listing valued Lemonade at $1.6 billion, that was lower than the market valuation of $2 billion in 2019 when it was private. The company sold a total of 11 million shares in its IPO.

Lemonade Inc. is expected to print <img.29 of loss per share in the fiscal second quarter

Lemonade launched pet health insurance last month

In the first quarter, the U.S. company had announced an over 100% increase in revenue to $26.2 million. In the second quarter, as per Zacks Investment Research, Lemonade is expected to register $1.29 of loss per share. As per experts, the insurance company is expected to note profits in triple-digits in the coming years.

Lemonade started business with a focus on home buyers and renter’s insurance. It is, however, committed to expanding its business and has recently launched a dedicated unit for pet health insurance. Lemonade also setup its business online that was well-received by the investors and is expected to be a major driver of growth in the future, as per the experts.

Loss ratio is a widely used metric that offers an insight into the profitability and health at large of an insurance company. The average loss ratio for an insurer lies in the range of 40% to 60%. Lemonade expresses confidence that it will conclude fiscal 2020 with a loss ratio of 72%. In comparison, the American insurer had a much higher loss ratio of 146% in 2018.

Lemonade’s gross written premiums jumped to $116 million in 2019

In terms of gross written premiums, Lemonade has seen a jump to $116 million in 2019 versus $9 million in 2017. As a result, it reported 94 cents of net losses in 2019 per dollar of gross written premiums versus $3.12 in 2017. Analysts currently recommend a range of $65 to $70 per share for investors looking forward to buying Lemonade’s shares. In late July, however, Goldman Sachs analysts slashed their price target for its stock by roughly 50%. Goldman Sachs served as an underwriter for Lemonade’s IPO.

Shares of the company closed at $67.40 on Monday that marks an over 125% increase as compared to its IPO price. Last week, the stock had pulled back to $56.86 per share that marked a new low for Lemonade since July 2nd. At the time of writing, the New York-based insurance company has a market capitalization of $3.70 billion.


Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

positive
negative
Published On
2020-08-11 09:00

avatar
About the Author
Khan is a professional trader and business writer with over 7 years of experience in several financial markets. Khan takes pride in sharing insightful articles with his readers that help them improve their investment portfolios.


buy-coffee
You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

Best Proxy for Bitcoin: Coinbase or IBIT
In this article, we’ll compare the iShares Bitcoin Trust to Coinbase to see which is the best proxy for Bitcoin on the stock market.
By Mike Sakuraba | 2 weeks ago

2 Under the Radar AI Stocks to Buy
If you’re tired of reading about NVIDIA, consider these two AI stocks to add while the chip market cools off.
By Mike Sakuraba | 2 weeks ago

3 Bold Predictions for the Second Quarter
So here’s what I’m expecting for the second quarter and I’ll throw in a couple of bold predictions as well!
By Mike Sakuraba | 2 weeks ago

2 Stocks Cathie Wood Keeps Buying That You Should Too
In the world of retail investing, Cathie Wood and her Ark Invest fund are extremely polarizing.
By Mike Sakuraba | 3 weeks ago

2 Under the Radar Stocks to Buy Before Others
One of the keys to investing has always been to identify weaknesses in stocks before others. Buy it when everyone hates it and when everyone loves it you’ll reap the rewards. Sounds easy enough right?
By Mike Sakuraba | 3 weeks ago

Better Crypto Stock Play: MicroStrategy or Coinbase?
I’ll look at two of the best crypto stocks and which one will be a better crypto play moving forward in this bull market.
By Mike Sakuraba | 4 weeks ago

2 Undervalued Chip Stocks to Buy
Here are 2 undervalued tech stocks I’m looking to buy.
By Mike Sakuraba | 4 weeks ago

Tesla (TSLA) Stock is on Life Support: When to Buy
Anyone who has bought the stock since it entered the S&P 500 in 2020 is now below water.
By Mike Sakuraba | 4 weeks ago